 |
|
|
Important Notice: The Forum does not endorse any medical
product or therapy. ALL medications and supplements
should be taken ONLY under the supervision of a physician,
due to the possibility of side-effects, drug interactions,
etc.
|
Drug:
|
ABT-107
|
|
Mode of action:
|
Nicotinic receptor modulator
|
|
Phase:
|
Discontinued
|
|
Company:
|
Abbott, Neurosearch
|
|
Note:
|
Halted March 2009
|
Prickaerts J, van Goethem NP, Chesworth R, Shapiro G, Boess
FG, Methfessel C, Reneerkens OA, Flood DG, Hilt D, Gawryl M,
Bertrand S, Bertrand D, König G. EVP-6124, a novel and
selective a7 nicotinic acetylcholine receptor partial
agonist, improves memory performance by potentiating the
acetylcholine response of a7 nicotinic acetylcholine
receptors. Neuropharmacology . 2012 Feb ; 62(2):1099-110. Abstract
See NeuroSearch
|
|
|
|
|
Text Size 
See our most recent Schizophrenia Bulletin theme Webinar: